Abstract LB-274: Identification and characterization of LY3410738, a novel covalent inhibitor of cancer-associated mutant Isocitrate Dehydrogenase 1 (IDH1)Nathan A. Brooks, Raymond Gilmour, Lisa Kays et al.|Cancer Research|2019Cited by 11
Abstract 6417: LY3410738, a novel inhibitor of mutant IDH1 is more effective than Ivosidenib and potentiates antileukemic activity of standard chemotherapy in preclinical models of acute myeloid leukemia (AML)Vivian Salama, Marina Konopleva, Nathan A. Brooks et al.|Cancer Research|2020Cited by 8